High prevalence of extensively drug-resistant and metallo beta-lactamase-producing clinical Acinetobacter baumannii in Iran

Microbial Pathogenesis

Volumn 98, Issue , 2016, Pages 155-159

  Maspi, Hossein ^a   Mahmoodzadeh Hosseini, Hamideh ^b   Amin, Mohsen ^c   Imani Fooladi, Abbas Ali ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; MBL; MDR; XDR

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; COLISTIN; FOSFOMYCIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; POLYMYXIN B; RIFAMPICIN; SULTAMICILLIN; TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLAGIM GENE; BLAIMP GENE; BLASIM GENE; BLASPM GENE; BLAVIM GENE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISK DIFFUSION; EXTENSIVELY DRUG RESISTANT ACINETOBACTER BAUMANNII; FEMALE; GENE; HUMAN; IRAN; LUNG LAVAGE; MALE; METALLO BETA LACTAMASE PRODUCING ACINETOBACTER BAUMANNII; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; IRAN; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 84979298711     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.07.011     Document Type: Article

References (37)

1. [1] Peleg, A.Y., Seifert, H., Paterson, D.L., Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21 (2008), 538–582.
2. [2] Sievert, D.M., Ricks, P., Edwards, J.R., Schneider, A., Patel, J., Srinivasan, A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010. Infect. Control Hosp. Epidemiol. 34 (2013), 1–14.
3. [3] Peymani, A., Nahaei, M.R., Farajnia, S., Hasani, A., Mirsalehian, A., Sohrabi, N., et al. High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn. J. Infect. Dis. 64 (2011), 69–71.
4. [4] Chuang, Y.C., Sheng, W.H., Li, S.Y., Lin, Y.C., Wang, J.T., Chen, Y.C., et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin. Infect. Dis. 52 (2011), 352–360.
5. [5] Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18 (2012), 268–281.
6. [6] Gupta, V., Datta, P., Chander, J., Prevalence of metallo-beta lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J. Infect. 52 (2006), 311–314.
7. [7] Maltezou, H.C., Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?. Int. J. Antimicrob. Agents, 33, 2009, 405 e1-7.
8. [8] Poirel, L., Magalhaes, M., Lopes, M., Nordmann, P., Molecular analysis of metallo-beta-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob. Agents Chemother. 48 (2004), 1406–1409.
9. [9] Nordmann, P., Poirel, L., Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8 (2002), 321–331.
10. [10] Yatsuyanagi, J., Saito, S., Harata, S., Suzuki, N., Ito, Y., Amano, K., et al. Class 1 integron containing metallo-beta-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan. Antimicrob. Agents Chemother. 48 (2004), 626–628.
11. [11] Patzer, J.A., Walsh, T.R., Weeks, J., Dzierzanowska, D., Toleman, M.A., Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006. J. Antimicrob. Chemother. 63 (2009), 269–273.
12. [12] Pitout, J.D., Chow, B.L., Gregson, D.B., Laupland, K.B., Elsayed, S., Church, D.L., Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J. Clin. Microbiol. 45 (2007), 294–298.
13. [13] Pickett, M.J., Greenwood, J.R., Identification of oxidase-positive, glucose-negative, motile species of nonfermentative bacilli. J. Clin. Microbiol. 23 (1986), 920–923.
14. [14] Hsueh, P.R., Ko, W.C., Wu, J.J., Lu, J.J., Wang, F.D., Wu, H.Y., et al. Consensus statement on the adherence to clinical and laboratory standards Institute (CLSI) antimicrobial susceptibility testing guidelines (CLSI-2010 and CLSI-2010-update) for enterobacteriaceae in clinical microbiology laboratories in taiwan. J. Microbiol. Immunol. Infect. Wei mian yu gan ran za zhi 43 (2010), 452–455.
15. [15] Owlia, P., Azimi, L., Gholami, A., Asghari, B., Lari, A.R., ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Le infezioni Med. Rivista Periodica di Eziologia, Epidemiologia, Diagnostica, Clin. e Terapia Delle Patologie Infettive 20 (2012), 182–187.
16. [16] Tripathi, P.C., Gajbhiye, S.R., Agrawal, G.N., Clinical and antimicrobial profile of Acinetobacter spp.: an emerging nosocomial superbug. Adv. Biomed. Res., 3, 2014, 13.
17. [17] Vincent, J.L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302 (2009), 2323–2329.
18. [18] Sinha, N., Agarwal, J., Srivastava, S., Singh, M., Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India. Indian J. Med. Microbiol. 31 (2013), 60–63.
19. [19] Rynga, D., Shariff, M., Deb, M., Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann. Clin. Microbiol. Antimicrob., 14, 2015, 40.
20. [20] Nie, X.M., Huang, P.H., Ye, Q.F., Wan, Q.Q., The distribution, drug resistance, and clinical characteristics of acinetobacter baumannii infections in solid organ transplant recipients. Transplant. Proc. 47 (2015), 2860–2864.
21. [21] Qi, L., Li, H., Zhang, C., Liang, B., Li, J., Wang, L., et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in acinetobacter baumannii. Front. Microbiol., 7, 2016, 483.
22. [22] Fazeli, H., Taraghian, A., Kamali, R., Poursina, F., NasrEsfahani, B., Moghim, S., Molecular identifiation and antimicrobial resistance profie of acinetobacter baumannii isolated from nosocomial infections of a teaching hospital in Isfahan, Iran. Avicenna J. Clin. Microb. Infec, 1, 2014, e21489.
23. [23] Principe, L., D'Arezzo, S., Capone, A., Petrosillo, N., Visca, P., In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann. Clin. Microbiol. Antimicrob., 8, 2009, 18.
24. [24] Jin, H., Xu, X.M., Mi, Z.H., Mou, Y., Liu, P., Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treatment within nosocomial settings. Chin. Med. J. 122 (2009), 301–306.
25. [25] Baran, G., Erbay, A., Bodur, H., Onguru, P., Akinci, E., Balaban, N., et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int. J. Infect. Dis. IJID Official Publ. Int. Soc. Infect. Dis. 12 (2008), 16–21.
26. [26] Lee, K., Yong, D., Jeong, S.H., Chong, Y., Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med. J. 52 (2011), 879–891.
27. [27] Peymani, A., Nahaei, M.R., Farajnia, S., Hasani, A., Mirsalehian, A., Sohrabi, N., et al. High prevalence of metallo-beta-lactamase-producing acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn. J. Infect. Dis. 64 (2011), 69–71.
28. [28] El-Ageery, S.M., Abo-Shadi, M.A., Alghaithy, A.A., Ahmad, M.A., Alsharif, N.H., Alharbi, S.A., Epidemiological investigation of nosocomial infection with multidrug-resistant Acinetobacter baumannii. Eur. Rev. Med. Pharmacol. Sci. 16 (2012), 1834–1839.
29. [29] Said, K.B.A.-J.A., Alrouji, M., Al-Harbi, H.O., Surveillance of antimicrobial resistance among clinical isolates recovered from a tertiary care hospital in Al Qassim, Saudi Arabia. Int. J. Health Sci. (Qassim) 8 (2014), 3–12.
30. [30] Ning, D., Li, D.-Z., Ji-chao, C., Yu-sheng, C., Rong, G., Ying-hui, H.U., Jing-ping, Y.J.D., Cheng-ping, H., Wei, Z., Jia-shu, L., Qin, Y., Huan-ying, W., Lan, M., Xiao-ning, Z., W, L.-P., Jian-jun, M., Qiu-yue, W., Ke, H., Gui-zhen, T., Shao-xi, C., R-qW, Bei H., Si-qin, W., Zhan-wei, W., Su-rui, Z., Zhan-cheng, G., Drugresistant genes carried by Acinetobacter baumannii isolated from patients with lower respiratory tract infection. Chin. Med. J. 123 (2010), 2571–2575.
31. [31] Farshadzadeh, Z., Hashemi, F.B., Rahimi, S., Pourakbari, B., Esmaeili, D., Haghighi, M.A., et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front. Microbiol., 6, 2015, 1146.
32. [32] Chang, K.C.L.M., Lin, N.T., Wu, W.J., Kuo, H.Y., Lin, T.Y., Yang, T.L., Chen, Y.C., Liou, M.L., Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan. J. Microbiol. Immunol. Infect. 45 (2012), 37–42.
33. [33] Fallah, F., Noori, M., Hashemi, A., Goudarzi, H., Karimi, A., Erfanimanesh, S., et al. Prevalence of bla NDM, bla PER, bla VEB, bla IMP, and bla VIM Genes among Acinetobacter baumannii Isolated from Two Hospitals of Tehran, Iran. Scientifica, 2014, 2014, 245162.
34. [34] Safari, M., Saidijam, M., Bahador, A., Jafari, R., Alikhani, M.Y., High prevalence of multidrug resistance and metallo-beta-lactamase (MbetaL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J. Res. Health Sci. 13 (2013), 162–167.
35. [35] Lee, K., Lee, W.G., Uh, Y., Ha, G.Y., Cho, J., Chong, Y., et al. VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg. Infect. Dis. 9 (2003), 868–871.
36. [36] John, S., Balagurunathan, R., Metallo beta lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii. Indian J. Med. Microbiol. 29 (2011), 302–304.
37. [37] Gillespie, S., McHugh, T., Antibiotic Resistance Protocols: Second Edition, Methods in Molecular Biology. 2010, Springer Science,Business Media LLC 2010.